Filing Details
- Accession Number:
- 0001562180-25-000328
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-13 16:30:45
- Reporting Period:
- 2025-01-10
- Accepted Time:
- 2025-01-13 16:30:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231427 | Christopher Patusky | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-01-10 | 5,000 | $175.43 | 5,900 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-01-10 | 300 | $358.65 | 5,600 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-01-10 | 600 | $359.82 | 5,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-01-10 | 969 | $361.04 | 4,031 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-01-10 | 1,930 | $362.03 | 2,101 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-01-10 | 1,092 | $362.95 | 1,009 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-01-10 | 109 | $363.86 | 900 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2025-01-10 | 5,000 | $0.00 | 5,000 | $175.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,000 | 2016-06-26 | 2025-06-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,100 | Indirect | By Trust |
Footnotes
- This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024.
- This transaction was executed in multiple trades at prices ranging from $358.11 to $358.895. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $359.12 to $360.095. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $360.395 to $361.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $361.485 to $362.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $362.49 to $363.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $363.80 to $364.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price.
Billionaire Hedge Funds
